Dickstein Jerome, Senyuk Vitalyi, Premanand Kavitha, Laricchia-Robbio Leopoldo, Xu Peng, Cattaneo Francesca, Fazzina Raffaella, Nucifora Giuseppina
Department of Pathology, University of Chicago, Chicago, IL 60637, USA.
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9783-8. doi: 10.1073/pnas.1004297107. Epub 2010 May 6.
By expressing EVI1 in murine bone marrow (BM), we previously described a myelodysplastic syndrome (MDS) model characterized by pancytopenia, dysmegakaryopoiesis, dyserythropoiesis, and BM failure. The mice invariably died 11-14 months after BM transplantation (BMT). Here, we show that a double point mutant EVI1-(1+6Mut), unable to bind Gata1, abrogates the onset of MDS in the mouse and re-establishes normal megakaryopoiesis, erythropoiesis, BM function, and peripheral blood profiles. These normal features were maintained in the reconstituted mice until the study was ended at 21 months after BMT. We also report that EVI1 deregulates several genes that control cell division and cell self-renewal. In striking contrast, these genes are normalized in the presence of the EVI1 mutant. Moreover, EVI1, but not the EVI1 mutant, seemingly deregulates these cellular processes by altering miRNA expression. In particular, the silencing of miRNA-124 by DNA methylation is associated with EVI1 expression, but not that of the EVI1 mutant, and appears to play a key role in the up-regulation of cell division in murine BM cells and in the hematopoietic cell line 32Dcl3. The results presented here demonstrate that EVI1 induces MDS in the mouse through two major pathways, both of which require the interaction of EVI1 with other factors: one, results from EVI1-Gata1 interaction, which deregulates erythropoiesis and leads to fatal anemia, whereas the other occurs by interaction of EVI1 with unidentified factors causing perturbation of the cell cycle and self-renewal, as a consequence of silencing miRNA-124 by EVI1 and, ultimately, ensues in BM failure.
通过在小鼠骨髓(BM)中表达EVI1,我们先前描述了一种骨髓增生异常综合征(MDS)模型,其特征为全血细胞减少、巨核细胞生成异常、红细胞生成异常和骨髓衰竭。这些小鼠在骨髓移植(BMT)后11 - 14个月 invariably死亡。在此,我们表明,一种无法结合Gata1的双点突变体EVI1-(1+6Mut)可消除小鼠MDS的发病,并重建正常的巨核细胞生成、红细胞生成、骨髓功能和外周血 profile。这些正常特征在重建的小鼠中得以维持,直至在BMT后21个月研究结束。我们还报告称,EVI1会使多个控制细胞分裂和细胞自我更新的基因失调。与之形成鲜明对比的是,在存在EVI1突变体的情况下,这些基因恢复正常。此外,EVI1而非EVI1突变体似乎通过改变miRNA表达来失调这些细胞过程。特别是,DNA甲基化导致的miRNA - 124沉默与EVI1表达相关,但与EVI1突变体的表达无关,并且似乎在小鼠BM细胞和造血细胞系32Dcl3中细胞分裂的上调中起关键作用。此处呈现的结果表明,EVI1通过两条主要途径在小鼠中诱导MDS,这两条途径均需要EVI1与其他因子相互作用:其一,源于EVI1 - Gata1相互作用,该相互作用使红细胞生成失调并导致致命性贫血,而另一条途径则是EVI1与未明确的因子相互作用,导致细胞周期和自我更新受到干扰,这是由于EVI1使miRNA - 124沉默所致,最终导致骨髓衰竭。